Paper Review Records
全部论文审稿周期
4 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
661
天
Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma
作者
Andrew Groves; Orville O Kirkland; Costanza Lo Cascio; Xiuqi Wang; Caleb Heaslip; Joana Graca Marques; Chen Song; Rebecca Poetschke; Tingjian Wang; Diana H Chin; Yaw Asante; Qi Liu; Hyunmin Kim; Shanqing Gu; Maria Trissal; Jenna Labelle; Gustavo Alencastro Veiga Cruzeiro; Kristen L Jones; Amy B Cameron; Louise M Clark; Brittaney Leeper; Quang-De Nguyen; Berkley E Gryder; Mariella G Filbin; Jun Qi展开收起
作者单位
1. Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA; 2. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA; 3. Division of Hematology/Oncology, University of Iowa Stead Family Children’s Hospital, Iowa City, Iowa, USA; 4. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; 5. Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA; 6. Department of Chemistry & Chemical Biology, Harvard University, Cambridge, Massachusetts, USA; 7. Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA; 8. Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA; 9. Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA展开收起
156
天
Multi-sampling allows intra-tumoral heterogeneity querying and vulnerability profiling in glioblastoma
作者
Diogo Moniz Garcia; Wan-Hsin Lin; Daniel P Wickland; Erik Jessen; Erik H Middlebrooks; Lauren E Haydu; Mieu Brooks; Ryan W Feathers; Lindsey Kinsella; Chris Sereduk; Steven S Rosenfeld; Nhan L Tran; Kaisorn L Chaichana; Panos Z Anastasiadis; Alfredo Quiñones-Hinojosa展开收起
作者单位
1. Department of Neurosurgery, Mayo Clinic, Florida, Jacksonville, FL, USA; 2. Department of Neurosurgery, Washington University, St. Louis, MO, USA; 3. Department of Cancer Biology, Mayo Clinic, Florida, Jacksonville, FL, USA; 4. Department of Quantitative Health Sciences, Mayo Clinic, Florida, Jacksonville, FL, USA; 5. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA; 6. Department of Radiology, Mayo Clinic, Florida, Jacksonville, FL, USA; 7. Department of Cancer Biology, Mayo Clinic, Arizona, Phoenix, AZ, USA; 8. Department of Neurology, Mayo Clinic, Florida, Jacksonville, FL, USA; 9. Department of Neurological Surgery, Mayo Clinic, Arizona, Phoenix, AZ, USA展开收起
224
天
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
作者
Dorsa Sadat Kiaei; Maxime Caru; Valérie Larouche; Emma Clini; Deepika Pugalenthi Saravanan; Sarah Lippé; Yves Théoret; Jean-Claude Décarie; Uri Tabori; Cynthia Hawkins; Benjamin Ellezam; Luis H Ospina; Léandra Desjardins; Marie-Élaine Métras; Serge Sultan; Édith Cantin; Marie-Ève Routhier; Chantal Mailloux; Marie-Claude Bertrand; Karim Estephan; Tara McKeown; Stéphanie Vairy; Geneviève Legault; Samuele Renzi; Éric Bouffet; Vijay Ramaswamy; Hallie Coltin; Lucie Lafay-Cousin; Juliette Hukin; Mélanie Alves; Tiffany Rent; Craig Erker; Nada Jabado; Mathieu Dehaes; Sébastien Perreault展开收起
作者单位
1. Department of Neurosciences, University of Montreal, CHU Sainte-Justine, Montreal, Canada; 2. Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State Health Children’s Hospital, Hershey, Pennsylvania, USA; 3. Department of Pediatrics, Division of Hematology-Oncology, CHU de Québec—Université Laval, Québec, Canada; 4. Department of Psychology, Université de Montréal, Montréal, Canada; 5. Centre de recherche Azrieli, CHU Sainte-Justine, Montreal, Canada; 6. Department of Pharmacology, CHU Sainte Justine, Montreal, Canada; 7. Medical Imaging Department, CHU Sainte-Justine, Montreal, Canada; 8. Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; 9. Division of Hematology Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada; 10. Department of Pathology, Hospital for Sick Children, Toronto, Canada; 11. Department of Pathology, CHU Sainte Justine, Montreal, Canada; 12. Department of Ophthalmology, CHU Sainte Justine, Montreal, Canada; 13. Department of Psychology, CHU de Québec—Université Laval, Québec, Canada; 14. Department of Pediatrics, Division of Pediatric Hematology-Oncology, CHU Sherbrooke, Québec, Canada; 15. Department of Pediatrics, Division of Neurology, Montreal Children’s Hospital, Québec, Canada; 16. Department of Hematology-Oncology, CHU Sainte-Justine, Montreal, Canada; 17. Department of Hematology-Oncology, Alberta Children’s Hospital, Alberta, Canada; 18. Department of pediatrics, Division of Hematology-Oncology, B.C. Children’s Hospital, University of British Columbia, Canada; 19. Division of Pediatric Hematology-Oncology, IWK Health Centre, Halifax, Nova Scotia, Canada; 20. Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada; 21. Departments of Pediatrics and Human Genetics, Division of Pediatric Hematology-Oncology, McGill University Health Center, Montreal, Canada; 22. Department of Radiology, Radio-oncology and Nuclear Medicine, University of Montreal, Montreal, Canada展开收起
150
天
Discrepancies in inter-rater agreement on resectability of recurrent glioblastoma: Complementary post-hoc analysis of the prospective, randomized DIRECTOR trial
作者
Philipp Karschnia; Nico Teske; Emilie Le Rhun; Hans-Georg Wirsching; Asgeir S Jakola; Constantin Roder; Daniel P Cahill; Einar O Vik-Mo; Mitchel S Berger; Jacob S Young; Wolfgang Wick; Ghazaleh Tabatabai; Joachim P Steinbach; Bogdana Suchorska; Katharine J Drummond; Lorenzo Bello; Marike L D Broekman; Michael A Vogelbaum; Yoshua Esquenazi; Oliver Schnell; Michael Weller; Joerg-Christian Tonn展开收起
作者单位
1. Department of Neurosurgery, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany (P.K., N.T., O.S.); 2. Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany; 3. German Cancer Consortium (DKTK), DFKZ Partner Site Munich, Munich, Germany (P.K., N.T., J.-C.T.); 4. Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland (E.L.R.); 5. Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland (H.-G.W., M.W.); 6. Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 7. Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden; 8. Department of Neurosurgery, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany; 9. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; 10. Department of Neurosurgery, Oslo University Hospital & Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; 11. Department of Neurosurgery & Division of Neuro-Oncology, University of San Francisco, San Francisco, CA, USA; 12. Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; 13. Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany; 14. Department of Neurology and Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Center for Neurooncology, Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany (G.T.); 15. German Cancer Consortium (DKTK), DFKZ Partner Site Tübingen, Tübingen, Germany (G.T.); 16. Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt, Germany; 17. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany (B.S.); 18. Department of Neurosurgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia; 19. Division for Neuro-Oncology, Department of Oncology and Hemato-Oncology, IRCCS Galeazzi Sant’Ambrogio, University of Milan, Milan, Italy; 20. Department of Neurosurgery, Haaglanden Medical Center, Leiden University Medical Center, Leiden, The Netherlands; 21. Department of Neurosurgery, Moffitt Cancer Center, Tampa, FL, USA; 22. Department of Neurosurgery, McGovern Medical School at UT Health Houston, Houston, TX, USA展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天